AGENUS INC
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 3 FORBES ROAD, LEXINGTON, MA, 02421
Mailing Address 3 FORBES ROAD, LEXINGTON, MA, 02421
Phone 781-674-4410
Fiscal Year End 1231
EIN 061562417
Financial Overview
FY2024
$313.91M
Total Assets
-$160.33M
Stockholders' Equity
$178.67M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 26, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 16, 2026 | View on SEC |
| 3 Initial insider ownership report | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 12, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
Material Events
8-K Strategy Change January 16, 2026
High Impact
- AGENUS received a $91 million cash infusion, significantly strengthening its balance sheet and extending its cash runway.
- The company has become 'asset-light', sharpening its focus on high-value R&D and drug innovation.
Related Companies
Companies in the same industry (SIC: 2836)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
CRISPR Therapeutics AG
CRSP Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.